South America vs Turkmenistan: Proportion of the target population who received the final dose of
South America
69.0%
in 2024
Turkmenistan
99.0%
in 2024
South America rank
4th
Turkmenistan rank
1st
Proportion of the target population who received the final dose of over time
- South America
- Turkmenistan
How they compare
Turkmenistan currently reports 99.0% against 69.0% in South America, a difference of 30.0%.
That makes Turkmenistan's figure about 1.4 times South America's.
Across all 8 years both countries report, Turkmenistan has been ahead every year.
South America ranks 4th and Turkmenistan ranks 1st of 35 groups.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South America | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.7% | 94.7% | 38.0% | Turkmenistan |
| 2020s | 54.4% | 98.6% | 44.2% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, South America or Turkmenistan?
- Turkmenistan, at 99.0% against 69.0% in South America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between South America and Turkmenistan?
- 30.0%, with Turkmenistan ahead.
- How many years of comparable data are there for South America and Turkmenistan?
- 8 years are reported by both, from 2017 to 2024.
- How do South America and Turkmenistan rank globally for proportion of the target population who received the final dose of?
- South America ranks 4th and Turkmenistan ranks 1st of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.